Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
TORONTO, Aug. 22, 2023 /CNW/ - The pan-Canadian Pharmaceutical Alliance (pCPA), consisting of participating federal, provincial, and territorial government public drug plans and the Canadian Generic...
TORONTO, April 20, 2021 /CNW/ - The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), in response to Federal Budget 2021. "The Canadian...
Ray Shelley of Apotex Elected Vice-Chair TORONTO, Feb. 22, 2021 /CNW/ - The Canadian Generic Pharmaceutical Association (CGPA) is pleased to announce the unanimous election of Mr. Jean-Guy Goulet,...
TORONTO, Oct. 5, 2020 /CNW/ - Canadians have saved close to $2-billion in prescription drug costs during the first half of the five-year agreement between the pan-Canadian Pharmaceutical Alliance...
TORONTO, June 17, 2020 /CNW/ - The Canadian Generic Pharmaceutical Association (CGPA) today released its Blueprint for a Sustainable Supply of Prescription Medicines for Canadians that identifies...
TORONTO, Dec. 10, 2019 /CNW/ - The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA) on the signing of a revised Canada-United States-Mexico...
TORONTO, June 12, 2019 /CNW/ - The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), on the Final Report of the Advisory Council on the...
PMRPB: Canadian price declines steepest of all OECD countries TORONTO, May 29, 2019 /CNW/ - New data released today by the federal government's Patented Medicine Prices Review Board (PMPRB) shows...
TORONTO, March 19, 2019 /CNW/ - The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), on Federal Budget 2019: "The Canadian Generic...
USMCA Concessions Latest Hit to Canadian Prescription Drug Costs TORONTO, Dec. 3, 2018 /CNW/ - Brand-name drug companies' research and development spending as a percentage of sales in Canada is less...
TORONTO, Oct. 1, 2018 /CNW/ - The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), on the pharmaceutical intellectual property aspects of the ...
TORONTO, Sept. 24, 2018 /CNW/ - A new poll confirms that Canadians do not want their access to generic and biosimilar medicines traded away under a new NAFTA deal. There are several proposals on the...
TORONTO, Sept. 5, 2018 /CNW/ - The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), on the resumption of trade negotiations between the...
TORONTO, April 9, 2018 /CNW/ - The Canadian Generic Pharmaceutical Association (CGPA) is pleased to announce the unanimous election of Mr. Peter Hardwick, Chief Commercial Officer and Executive Vice...
TORONTO, Jan. 29, 2018 /CNW/ - On behalf of participating federal, provincial, and territorial public drug plans, the pan-Canadian Pharmaceutical Alliance (pCPA), with the Canadian Generic...
Canada must not concede longer market monopolies in NAFTA discussions TORONTO, Nov. 14, 2017 /CNW/ - Brand-name drug companies' research and development spending as a percentage of sales in Canada is ...
Jean-Guy Goulet of Pharmascience Elected Vice Chair TORONTO, Oct. 2, 2017 /CNW/ - The Canadian Generic Pharmaceutical Association (CGPA) is pleased to announce the election of Mr. Doug Sommerville,...
MONTREAL, July 16, 2017 /CNW Telbec/ - The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), regarding the agreement in principle announced...
MONTREAL, June 28, 2017 /CNW Telbec/ - The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), regarding the Government of Quebec's plan to...
Doug Sommerville of Teva Canada Elected Vice Chair TORONTO, Feb. 27, 2017 /CNW/ - The Canadian Generic Pharmaceutical Association (CGPA) is pleased to announce the election of Mr. Larry MacGirr,...
TORONTO, Oct. 17, 2016 /CNW/ - Greater regulatory convergence is needed to ensure a consistent supply of safe, effective and high-quality generic medicines in Canada, according to a new study...
TORONTO, Sept. 12, 2016 /CNW/ - Brand-name drug companies' research and development spending as a percentage of sales in Canada is less than half of the 10% the industry committed to when their...
12th Consecutive Year that 10% Commitment Has Not Been Met TORONTO, Jan. 11, 2016 /CNW/ - Brand-name drug companies' research and development spending as a percentage of sales in Canada has dropped...
TORONTO, Sept. 14, 2015 /CNW/ - Canada is hosting the 18th Annual International Generic Pharmaceutical Alliance (IGPA) Conference from September 16 through 18, 2015 at Toronto's Westin Harbour Castle ...
TORONTO, April 7, 2015 /CNW/ - The Canadian Generic Pharmaceutical Association (CGPA) announced today the establishment of a new CGPA Biosimilars Board and the election of Michel Robidoux, President...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.